David Sheppard has been a leader in the medical device industry for more than 30 years. His experience includes positions such as GM and VP, as well as high impact sales and marketing leadership roles at major Fortune 500 corporations (Medtronic/Covidien, BD/Bard, Cooper and Ciba). His achievements also involve work at startup organizations (including working pre-IPO on a successful IPO company). As a managing director at MedWorld Advisors, Sheppard is focused on exit strategies for the MedDevice, BioTech, DentalTech, DigitalHealthTec, and OEM Medtech companies. For M&A, the goal is to help small- and medium-sized companies maximize their value with their exit strategy and/or achieve success with their acquisition strategy. Having completed international/cross-border deals, an important component to MedWorld’s success is its global reach and ability to cross boundaries to successfully facilitate transactions. In addition to M&A achievements at MedWorld Advisors, his medtech career worldwide results include completing distribution and licensing deals with international businesses, comprised of major Fortune 500 companies (e.g., GE, Philips, Stryker, NK, Mindray, etc.) as well as smaller entities. These experiences have led to a global network of contacts with channel partners both large and small. Sheppard has been involved in “go-to-market” strategies on every major developed continent (Europe, Asia, Africa, Australia, North and South America).